Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just saw Intellia (NTLA) popped 3.56% to $14.27 after FDA finally lifted the hold on their MAGNITUDE Phase 3 trial. They had to pause things back in October when one patient hit some liver issues, but looks like they cleared it. The hold on is off now and they're moving forward with enrollment.
What's interesting is they already resolved the hold on the MAGNITUDE-2 trial back in January too. CEO basically said now they can focus on finishing both trials. This is a pretty big deal for their ATTR cardiomyopathy treatment (nexiguran ziclumeran). If this works out, could be massive for that patient population. Market seems to be buying it.